IBDEI14W ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,20315,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,20315,1,5,0)
 ;;=5^Subacute LL,In Remission
 ;;^UTILITY(U,$J,358.3,20315,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,20316,0)
 ;;=204.22^^131^1286^115
 ;;^UTILITY(U,$J,358.3,20316,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20316,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,20316,1,5,0)
 ;;=5^Subacute LL,In Relapse
 ;;^UTILITY(U,$J,358.3,20316,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,20317,0)
 ;;=205.02^^131^1286^5
 ;;^UTILITY(U,$J,358.3,20317,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20317,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,20317,1,5,0)
 ;;=5^AML,In Relapse
 ;;^UTILITY(U,$J,358.3,20317,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,20318,0)
 ;;=205.12^^131^1286^20
 ;;^UTILITY(U,$J,358.3,20318,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20318,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,20318,1,5,0)
 ;;=5^CML,In Relapse
 ;;^UTILITY(U,$J,358.3,20318,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,20319,0)
 ;;=284.81^^131^1286^14
 ;;^UTILITY(U,$J,358.3,20319,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20319,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,20319,1,5,0)
 ;;=5^Aplastic Anemia d/t Drugs
 ;;^UTILITY(U,$J,358.3,20319,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,20320,0)
 ;;=284.89^^131^1286^13
 ;;^UTILITY(U,$J,358.3,20320,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20320,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,20320,1,5,0)
 ;;=5^Aplastic Anemia d/t Chronic Disease
 ;;^UTILITY(U,$J,358.3,20320,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,20321,0)
 ;;=289.84^^131^1286^119
 ;;^UTILITY(U,$J,358.3,20321,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20321,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,20321,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,20321,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,20322,0)
 ;;=V10.91^^131^1286^67
 ;;^UTILITY(U,$J,358.3,20322,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20322,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,20322,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,20322,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,20323,0)
 ;;=V10.91^^131^1286^66
 ;;^UTILITY(U,$J,358.3,20323,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20323,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,20323,1,5,0)
 ;;=5^H/O Malignant Neoplasm,Unspec
 ;;^UTILITY(U,$J,358.3,20323,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,20324,0)
 ;;=465.9^^131^1287^70
 ;;^UTILITY(U,$J,358.3,20324,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20324,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,20324,1,5,0)
 ;;=5^URI
 ;;^UTILITY(U,$J,358.3,20324,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,20325,0)
 ;;=462.^^131^1287^61
 ;;^UTILITY(U,$J,358.3,20325,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20325,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,20325,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,20325,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,20326,0)
 ;;=466.0^^131^1287^3
 ;;^UTILITY(U,$J,358.3,20326,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20326,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,20326,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,20326,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,20327,0)
 ;;=112.1^^131^1287^79
 ;;^UTILITY(U,$J,358.3,20327,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20327,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,20327,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,20327,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,20328,0)
 ;;=616.0^^131^1287^13
 ;;^UTILITY(U,$J,358.3,20328,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,20328,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,20328,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,20328,2)
 ;;=^21925
